Background This study aimed to evaluate the cut-off value of anti-Müllerian hormone (AMH)
combined with body mass index (BMI) in the diagnosis of polycystic ovary syndrome (PCOS) …

The aim of this study was to ascertain whether higher levels of serum anti-Müllerian
hormone (AMH) are associated with the ovarian follicular arrest in women with polycystic …

Background: Anti-Müllerian hormone (AMH) is suggested as an important marker for women
with polycystic ovary disease (PCOS). Several studies have found serum level of AMH …

STUDY QUESTION Can serum anti-Müllerian hormone (AMH) replace polycystic ovary
morphology (PCOM) determined by ultrasound as a diagnostic component of polycystic …

A variety of predictors are available for ovarian stimulation cycles in assisted reproductive
technology (ART) forecasting ovarian response and reproductive outcome in women …

The conflicting results from studies on the predictive capabilities of serum anti-Müllerian
hormone (AMH) for IVF pregnancy outcomes may be attributed to small sample sizes and …

Aim The present study was conducted to correlate serum AMH levels with Polycystic Ovarian
Syndrome (PCOS) and type of treatment protocol. Materials and Methods Serum AMH levels …

OBJECTIVE: The use of oral contraceptive (OC) pills alters the characteristic features of
polycystic ovary syndrome (PCOS) complicating the diagnosis of this disease. Anti-Müllerian …

Objective To determine whether a patient-specific predictive model combining antimüllerian
hormone (AMH) levels and body mass index (BMI) can aid in the diagnosis of polycystic …

Background: ANTI-MULLERIAN HORMONE (AMH) levels may represent the ovarian
follicular pool and could be a useful marker of ovarian reserve. The clinical application of …